Media coverage about Biogen (NASDAQ:BIIB) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable.....More>>>
&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-659769976&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/659769976/960×0.jpg?fit=scale&q; data-height=&q;634&q; data-width=&q;960&q;&g; Shutterstock
It&s;s the unusually diverse nature of the list that&s;s fascinating. Lots of different types of industries and sectors. Some are reasonably well-known, others....More>>>
We have been long Novartis (NVS) for over a year now and its first quarter earnings report did nothing to change our long-term view. Wall Street didn’t take too kindly to the sequential decline in sales of cosentyx, which made shares drop to below $75 a share in the aftermath. However, shares have now printed a weekly swing low, which may mean the bottom is in.
Question marks surrounding....More>>>
Strong minds discuss ideas, average minds discuss events, weak minds discuss people.” – Socrates
I received an inquiry from a real-time follower yesterday around an “off the radar” concern that rarely comes up in conversation but it is a name I own a few shares in. Given it is selling right at the same level as it was when I did an exclusive “first look”....More>>>
As expected, the year’s first unicorn was a winner. Cybersecurity provider Zscaler (Pending:ZS) priced well above its range and shot up 106% on its debut. That’s good news for next week’s Dropbox (Pending:DBX). Investors are paying up for growth, which should lure even more unicorns to market. This past week also saw the year’s first bank IPO and the year’s largest....More>>>
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Some of the biggest gainers among Manufacturing stocks include:
Flex Pharma Inc Cmn (FLKS): FLKS stock is up 13.55% today. Egalet Corporation (EGLT): EGLT stock is up 12.41% today. Versartis Inc Cmn (VSAR): VSAR stock is up 10.15% today. Dynavax Technologies (DVAX): DVAX stock....More>>>
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.
Welcome to another edition of “3 Things In Biotech You Should Learn Today,” a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.
Merck buys into oncolytic virus therapy
Company: Merck (MRK)
Deals and Financings
Tianjin Tasly Pharma (SHA: 600535) is in talks to IPO its biopharma division in Hong Kong later this year with the goal of raising $1 billion. If it happens, the IPO will probably be Hong Kong’s largest biopharma IPO this year. Tasly, known for its TCM offerings, has been actively using M&A to expand into biologics. It has also invested in C-Bridge Capital’s....More>>>
In response to the company sharing more details of a phase 3 study with investors, shares ofSpectrum Pharmaceuticals(NASDAQ:SPPI), a small-cap biotech focused onhematology and oncology, jumped 16% as of 12:40 p.m. EDT onThursday.
The study in questionis called ADVANCE. This phase 3 trial was designed to demonstrate noninferiority of Spectrum’s drug Rolontis when compared....More>>>
Analysis focus: LOXO
Loxo Oncology (NASDAQ:LOXO), which was recently covered in a series of excellent articles by our very own Dr. Zach Hartman, PhD, who collaborates with the Total Pharma Tracker and whose members saw an early view of the series (…and so on), is up strongly following preliminary results which showed that its new LOXO-292 experimental cancer drug led to tumor shrinkage....More>>>